Your browser doesn't support javascript.
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Mellinghoff, Sibylle C; Mayer, Leonie; Robrecht, Sandra; Weskamm, Leonie M; Dahlke, Christine; Gruell, Henning; Schlotz, Maike; Vanshylla, Kanika; Schloser, Hans A; Thelen, Martin; Fink, Anna-Maria; Fischer, Kirsten; Klein, Florian; Addo, Marylyn M; Eichhorst, Barbara; Hallek, Michael; Langerbeins, Petra.
  • Mellinghoff SC; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Depa
  • Mayer L; Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partn
  • Robrecht S; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne.
  • Weskamm LM; Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partn
  • Dahlke C; Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partn
  • Gruell H; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne.
  • Schlotz M; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne.
  • Vanshylla K; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne.
  • Schloser HA; Centre for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne.
  • Thelen M; Centre for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne.
  • Fink AM; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne.
  • Fischer K; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne.
  • Klein F; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Centre for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and Univers
  • Addo MM; Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partn
  • Eichhorst B; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne.
  • Hallek M; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne.
  • Langerbeins P; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne.
Haematologica ; 107(10): 2480-2484, 2022 10 01.
Article in English | MEDLINE | ID: covidwho-1902909

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Haematologica Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Haematologica Year: 2022 Document Type: Article